Drug Known as Proxalutamide Accelerates COVID-19 Viral Clearance While Reducing Time to Clinical Remission
A joint American and Brazilian team recently studied a drug called proxalutamide as a treatment for COVID-19. A nonsteroidal antiandrogen […]
A joint American and Brazilian team recently studied a drug called proxalutamide as a treatment for COVID-19. A nonsteroidal antiandrogen […]
A randomized, placebo-controlled study led by researchers from Mexico involving 243 patients led to the conclusion of investigators that supports […]
TrialSite recently introduced the Nigerian-based IVERCOVID study. In an interview with the principal investigator Professor Olufemi Babalola, an ophthalmologist and […]
Back in May 2020, TrialSite announced the study titled a pilot clinical trial led by Egypt’s Mansoura University, located in […]
Recently, Xavier Nogués from the Autonomous University of Barcelona Department of Medicine and other prominent Spanish academic medical centers recently […]
Researchers from health systems conducted a retrospective observational study out of the Dominican Republic, a nation that has been using […]
Gamida Cell presented results of a Phase 3 clinical study of omidubicel in an oral session at the Transplantation & […]
ARVOBIO presented results from three ongoing clinical trials evaluating its lentiviral gene therapies: a phase II study assessing AVR-RD-01 for […]
PaxMedica announced positive results from a phase 2 dose-ranging clinical trial evaluating PAX-124890-=101 demonstrated sustained improvements over placebo in the […]
KalVista Pharmaceuticals reported positive topline data from a Phase 2 clinical trial evaluating KVD900 as an oral on-demand treatment for […]